SynthesisAdipocyte2025
Molecular mechanisms of propolis in adipogenesis, lipid metabolism and white adipose tissue Browning: a systematic review of preclinical studies.
Synthesis in Adipocyte, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
White adipose tissue (WAT) browning has gained increasing attention as potential strategy for obesity management. The conversion of WAT into brown adipose tissue (BAT) enhances energy expenditure and improves metabolic health. Propolis, natural resinous substance produced by honeybees, contains bioactive compounds such as caffeic acid phenethylester, chrysin and quercetin, which are thought to regulate adipogenesis and promote WAT browning. This systematic review aimed to synthesize preclinical evidence on the molecular mechanisms by which propolis and its bioactive compounds regulate adipogenesis, lipid metabolism and the browning of white adipose tissue. We conducted a systematic search of electronic databases, including PubMed, Scopus and Google Scholar, without time restrictions, using relevant keywords related to propolis and obesity. A total of 7 preclinical studies (animal and in vitro) met the inclusion criteria. These studies indicate that propolis and its bioactive compounds, modulate adipogenic transcription factors, reduce lipid accumulation and increase expression of browning markers in cellular and animal models. Studies in vivo demonstrate reductions in body weight, fat accumulation and adipocyte differentiation, accompanied by increased thermogenesis. Preclinical evidence suggests that propolis modulates adipogenesis, lipid metabolism and WAT browning; however, clinical trials assessing mechanistic endpoints are lacking and necessary before translational recommendations can be made.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.